IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label KEI. Show all posts
Showing posts with label KEI. Show all posts
Thursday, 20 May 2021

mRNA Vaccine Patents Study

›
Mario Gaviria and Burcu Kilic have published an interesting article titled, “A Network Analysis of Covid-19 mRNA Vaccine Patents.”  The arti...
Friday, 27 October 2017

Another Case of Pharma Weakening the Patent System (and University Technology Transfer)

›
The LA Times recently published an article, "UCLA’s Efforts to Patent a Costly Patent Cancer Drug in India Hurts the Poor, Critics ...
›
Home
View web version
Powered by Blogger.